Semaglutide 10mg — GLP-1 Research Peptide
Semaglutide 10mg — GLP-1 Research Peptide Price range: $127.49 through $149.99
Back to products
Semax 10mg — Research Peptide (ACTH 4–10 Analog)
Semax 10mg — Research Peptide (ACTH 4–10 Analog) Price range: $42.49 through $49.99

Retatrutide 10mg — Triple Agonist GLP-1/GIP/Glucagon Research Peptide

Original price was: $179.99.Current price is: $149.99.

Limited Batch Release — Only While Stock Lasts
• 99% Purity • Research Use Only

Bulk Discounts:
Buy 3, save 10% • Buy 5, save 15%

High-purity laboratory peptide supplied with certified COAs and independent third-party testing documentation for advanced research use.

Discount per Quantity

QuantityDiscountPrice
3 - 410%$134.99
5 +15%$127.49
Category:
Description

Uncompromising Quality Control

At Lab Trust Peptides, quality assurance is integrated into every stage of sourcing, production, and verification. Each peptide is supplied with a comprehensive Certificate of Analysis (COA) providing both qualitative and quantitative data to support transparency, traceability, and reproducibility in laboratory environments.

Advanced analytical testing — including LCMS screening, heavy metal analysis, endotoxin testing, and sterility verification — is conducted across commonly requested research compounds to maintain consistent quality standards.

Every batch undergoes strict quality review, with routine randomized full-panel testing performed by independent laboratories to ensure analytical reliability and batch consistency.

Quality Comparison

Feature / Testing Standard Lab Trust Peptides Other Labs (Avg.)
Standard COA (Qualitative & Quantitative) ✔ Included with every batch ✖ Often incomplete
LCMS Screening ✔ Available on most compounds ✖ Rarely provided
Heavy Metals, Endotoxin & Sterility Testing ✔ Conducted with ongoing verification ✖ Frequently not performed
Batch-to-Batch Consistency Testing ✔ Required ✖ Variable
Quality Track Record ✔ Consistent analytical performance ✖ Inconsistent outcomes

Retatrutide – Research Overview

Retatrutide is an investigational synthetic peptide classified as a triple agonist targeting GLP-1, GIP, and glucagon receptors. Its multi-receptor activity makes it a valuable model compound for laboratories investigating complex metabolic signaling, endocrine interactions, and receptor-mediated hormone pathways.

Research interest focuses on its interaction with multiple hormonal systems simultaneously, supporting advanced experimental models designed to explore integrated metabolic regulation.

Research Context

In controlled research environments, Retatrutide has been examined in relation to:

  • Triple-receptor signaling models: Investigation of GLP-1, GIP, and glucagon pathway interactions.
  • Metabolic regulation research: Studies focused on endocrine signaling dynamics.
  • Energy balance mechanisms: Evaluation of hormone-linked metabolic processes.
  • Glucose and lipid pathway analysis: Exploration of multi-pathway metabolic responses.

These observations are exploratory and not conclusive.

Format & Handling

Compounds are supplied in sterile laboratory glass vials containing lyophilized peptide material. Reconstitution should be performed using bacteriostatic water or appropriate laboratory solvents according to established research protocols.

Vials should be stored and handled in accordance with institutional laboratory standards to preserve stability, purity, and analytical integrity.

Trusted by 15,000+ Researchers

Consistent purity. Verified documentation. Reliable cold-chain delivery.

Dr. Sarah Chen
Research Scientist
★★★★★

“Outstanding purity & consistency. COA documentation is thorough and cold-chain shipping protects product integrity.”

Dr. Michael Johnson
Lab Director
★★★★★

“Exceptional quality control & customer service. Same-day shipping supports time-sensitive research work.”

Dr. Amanda Lee
Principal Investigator
★★★★★

“Reliable supplier with verified 99%+ purity. Excellent value for high-end research applications.”

Intended Use: Research use only.

Not for human consumption, medical, veterinary, or diagnostic use. Research findings are preliminary and do not imply safety or efficacy.